Further experiments are needed to investigate whether RBM4 interacts directly with Bcl-x and SRSF1 or binds to other splicing factors to suppress tumor progression in vitro and in mouse models of gastric cancer. This evidence concerns the gene BCL2L1 and gastric cancer.